High dose induction therapy with interferon alpha followed by combination therapy for naive hepatitis C patients - Results of a multicenter randomized controlled study.

被引：0
|
作者：
Kaiser, S
Kreysel, C
Zeitz, M
Schneider, W
Gregor, M
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] Univ Homburg, D-6650 Homburg, Germany
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1608
引用
收藏
页码：561A / 561A
页数：1
相关论文
共 50 条
  • [31] Interferon-alfa induction treatment with or without ribavirin in chronic hepatitis C: A multicenter randomized controlled study.
    Senturk, H
    Ersoz, G
    Ozaras, R
    Kaymakoglu, S
    Bozkaya, H
    Akdogan, M
    Mert, A
    Bozdayi, M
    Ozbay, G
    HEPATOLOGY, 2002, 36 (04) : 579A - 579A
  • [32] Leukocyte interferon-alpha and ribavirin in combination vs recombinant interferon alpha-2b and ribavirin combination for treatment of naive patients with chronic hepatitis C: A multicenter Italian study.
    Barbarini, G
    Pellicelli, A
    Fruttaldo, L
    Bacca, D
    Babudieri, S
    Torre, D
    Francavilla, R
    Rizzo, G
    Annese, M
    Grimaldi, M
    Zaccarini, P
    Wassermann, A
    Barbaro, G
    HEPATOLOGY, 2001, 34 (04) : 593A - 593A
  • [33] The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naive chronic hepatitis C patients
    Dai, CY
    Yu, ML
    Chuang, WL
    Hou, NJ
    Hou, C
    Chen, SC
    Lin, ZY
    Hsieh, MY
    Wang, LY
    Chang, WY
    ANTIVIRAL RESEARCH, 2002, 53 (01) : 9 - 18
  • [34] Induction treatment with high dose interferon alpha combined with ribavirin and amantadine for treatment naive patients with chronic hepatitis C a 2 arm randomised pilot study.
    Sentjens, R
    Beld, M
    Weegink, C
    Reesink, H
    HEPATOLOGY, 2002, 36 (04) : 577A - 577A
  • [35] Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy
    Rosen, HR
    Ribeiro, RR
    Weinberger, L
    Wolf, S
    Chung, MJ
    Gretch, DR
    Perelson, AS
    JOURNAL OF HEPATOLOGY, 2002, 37 (01) : 124 - 130
  • [36] Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial
    Fontana, RJ
    Israel, J
    LeClair, P
    Banner, BF
    Tortorelli, K
    Grace, N
    Levine, RA
    Fiarman, G
    Thiim, M
    Tavill, AS
    Bonkovsky, HL
    HEPATOLOGY, 2000, 31 (03) : 730 - 736
  • [37] The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C
    Chemello, L
    Cavalletto, L
    Bernardinello, E
    Guido, M
    Pontisso, P
    Alberti, A
    JOURNAL OF HEPATOLOGY, 1995, 23 : 8 - 12
  • [38] LOW-DOSE ALPHA-INTERFERON THERAPY CAN BE EFFECTIVE IN CHRONIC ACTIVE HEPATITIS-C - RESULTS OF A MULTICENTER, RANDOMIZED TRIAL
    SANCHEZTAPIAS, JM
    PLANAS, R
    FORNS, X
    AMPURDANES, S
    LI, TT
    VIVER, JM
    MORILLAS, R
    ACERO, D
    MAS, P
    LLOVET, JM
    RODES, J
    GASTROENTEROLOGY, 1995, 108 (04) : A1162 - A1162
  • [39] Pilot study of interferon-α high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C
    Berg, T
    Naumann, U
    Wiedenmann, B
    Hopf, U
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (02): : 145 - +
  • [40] Effect of combination therapy of interferon alpha and ribavirin in the patients with chronic hepatitis C
    Kim, Seok Hyn
    Lee, Byung Seok
    Lee, Heon Young
    Lee, Tae Hee
    Kang, Young Woo
    Park, Jeong Hoon
    Kim, Hong Su
    Kim, Suk Bae
    Song, Il Han
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A467 - A467
12345